General Information of the Compound
| Compound ID |
CP0130819
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-Phenyl-1-(5-phenyl-oxazol-2-yl)-heptan-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
7-phenyl-1-(5-phenyl-1,3-oxazol-2-yl)heptan-1-one
7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one
BDBM50163187
CHEMBL173992
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H23NO2
|
||||||||||||||||||
| Molecular Weight |
333.431
|
||||||||||||||||||
| Canonical SMILES |
O=C(CCCCCCc1ccccc1)c1ncc(o1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H23NO2/c24-20(16-10-2-1-5-11-18-12-6-3-7-13-18)22-23-17-21(25-22)19-14-8-4-9-15-19/h3-4,6-9,12-15,17H,1-2,5,10-11,16H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
GEHXWVPLQWJJQM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one )
| Drug Name | 7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one | ||
|---|---|---|---|